SOD1 and type 2 diabetes mellitus: RA treatment increased the serum levels of SOD and IL-4 and decreased the serum levels of MDA, IL-1β, TNF-α, INF-γ and IL-6 in the rats with T2D, showing RA treatment could alleviate oxidative and inflammatory stress with the development of T2D.